Biomagnetik Park AG

Building on the results of 20 years of research, we are creating a semi-open platform that for the first time opens up the huge potential for magnetocardiography (MCG) with the most sensitive quantum sensors for accurate diagnostics in cardiology, precision medicine and drug development. We will deliver a revolutionary MCG platform from 2027 consisting of:. Speed and accuracy are not opposites when using state-of-the-art methods. The power of the bmp diagnostic is founded on several basic electrophysical parameters/methods, developed by bmp 2005 – 2022. The results are based on datasets from 2002-2004 provided by the Klinikum Hoyerswerda, Germany. The PoC is based on long-term data sets provided by the Franz-Volhard-Klinik Charité Campus Buch (research group Prof. Magnetoionography (MIG) is a new method, derived from MCG and patented by bmp in August 2022, which allows for the first time to characterize these individual ion currents in heart muscle cells. Magnetorelaxometry (MRX) or superparamagnetic relaxometry (SPMR) is a technology that utilizes SQUID sensors and superparamagnetic nanoparticles (NPs) to detect diseased tissues.